SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION
The prescribed route of administration for each Systemic Anti-Cancer Therapy Drug Administration in a Systemic Anti-Cancer Therapy Drug Cycle.
Description
The prescribed route of administration for each Systemic Anti-Cancer Therapy Drug Administration in a Systemic Anti-Cancer Therapy Drug Cycle.
National codes:
National Codes
Code | Description |
---|---|
01 | Intravenous |
02 | Oral |
03 | Intrathecal |
04 | Intramuscular |
05 | Subcutaneous |
06 | Intraarterial |
07 | Intraperitoneal |
08 | Other intracavity Intracavernous |
09 | Intravesical (Intra-Vesicular) |
10 | Intratumour / Intralesional (Retired 1 September 2019 ) |
11 | Cutaneous (Topical) |
12 | Intradermal |
13 | Intratumour |
14 | Intralesional |
99 | Other (Retired 1 September 2019 ) |
98 | Other (not listed) |
Also Known As
This attribute is also known by these names:
Context | Alias |
---|---|
Plural | SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTES OF ADMINISTRATION |
Where Used
Type | Link | How used |
---|---|---|
Class | CLINICAL INTERVENTION | has an attribute SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION of type SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION |
Data Element | SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION | is the data element of SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION |